• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

干扰素用于治疗多发性硬化症的简史。

A brief history of the use of interferons as treatment of multiple sclerosis.

作者信息

Jacobs L, Johnson K P

机构信息

Department of Neurology, University at Buffalo, NY.

出版信息

Arch Neurol. 1994 Dec;51(12):1245-52. doi: 10.1001/archneur.1994.00540240089022.

DOI:10.1001/archneur.1994.00540240089022
PMID:7986181
Abstract

Interferons (IFNs) are a family of glycoproteins that are naturally secreted by certain cells in response to viral infection. The naturally occurring IFNs confer protection on other cells, preventing them from becoming infected, a phenomenon referred to as "virus interference" by Isaacs and Lindenmann in the first description of these proteins. In addition to their antiviral properties, the IFNs also have complex immunomodulatory, antiproliferative, and hormonelike activities, which are not completely understood.

摘要

干扰素(IFNs)是一类糖蛋白,由某些细胞在受到病毒感染时自然分泌。天然存在的干扰素能保护其他细胞,防止它们被感染,这一现象在这些蛋白质首次被描述时,被艾萨克斯和林登曼称为“病毒干扰”。除了具有抗病毒特性外,干扰素还具有复杂的免疫调节、抗增殖和类似激素的活性,其作用机制尚未完全明确。

相似文献

1
A brief history of the use of interferons as treatment of multiple sclerosis.干扰素用于治疗多发性硬化症的简史。
Arch Neurol. 1994 Dec;51(12):1245-52. doi: 10.1001/archneur.1994.00540240089022.
2
Treatment of multiple sclerosis with various interferons: the cons.使用多种干扰素治疗多发性硬化症:反对观点
Neurology. 1988 Jul;38(7 Suppl 2):62-5.
3
Evaluation of antiviral effect of type I, II, and III interferons on direct-acting antiviral-resistant hepatitis C virus.评价 I、II 和 III 型干扰素对直接作用抗病毒药物耐药性丙型肝炎病毒的抗病毒效果。
Antiviral Res. 2017 Oct;146:130-138. doi: 10.1016/j.antiviral.2017.08.017. Epub 2017 Aug 31.
4
Type I interferons in the pathogenesis and treatment of canine diseases.I型干扰素在犬类疾病发病机制及治疗中的作用
Vet Immunol Immunopathol. 2017 Sep;191:80-93. doi: 10.1016/j.vetimm.2017.08.006. Epub 2017 Aug 26.
5
Recombinant interferons alpha and gamma: comparative antiviral activity and synergistic interaction in encephalomyocarditis virus infection of mice.
Antiviral Res. 1987 Nov;8(4):209-21. doi: 10.1016/0166-3542(87)90075-1.
6
Interferons and multiple sclerosis.干扰素与多发性硬化症
Biomed Pharmacother. 1989;43(5):355-60. doi: 10.1016/0753-3322(89)90061-9.
7
The effects of recombinant and natural human interferons in vaccinia virus infected rhesus monkeys.重组人干扰素和天然人干扰素对感染痘苗病毒的恒河猴的影响。
Antiviral Res. 1985;Suppl 1:199-207. doi: 10.1016/s0166-3542(85)80029-2.
8
Interferons in dermatology.皮肤科中的干扰素
J Am Acad Dermatol. 1989 Apr;20(4):650-6. doi: 10.1016/s0190-9622(89)70078-5.
9
Implications for clinical application of new developments in interferon research.
Biochim Biophys Acta. 1982 Sep 30;695(1):49-67. doi: 10.1016/0304-419x(82)90006-3.
10
Antiviral and side effects of interferons produced by recombinant DNA techniques as tested in rhesus monkeys.
Antiviral Res. 1982 Oct;2(5):313-8. doi: 10.1016/0166-3542(82)90054-7.

引用本文的文献

1
Disease-modifying therapy in progressive multiple sclerosis: a systematic review and network meta-analysis of randomized controlled trials.进展性多发性硬化症的疾病修正治疗:随机对照试验的系统评价和网状Meta分析
Front Neurol. 2024 Mar 11;15:1295770. doi: 10.3389/fneur.2024.1295770. eCollection 2024.
2
Twenty Years of Subcutaneous Interferon-Beta-1a for Multiple Sclerosis: Contemporary Perspectives.皮下注射干扰素β-1a治疗多发性硬化症二十年:当代观点
Neurol Ther. 2024 Apr;13(2):283-322. doi: 10.1007/s40120-023-00565-7. Epub 2024 Jan 11.
3
Interferons and Multiple Sclerosis: Lessons from 25 Years of Clinical and Real-World Experience with Intramuscular Interferon Beta-1a (Avonex).
干扰素与多发性硬化症:肌肉内注射干扰素 β-1a(倍泰龙)25 年的临床与真实世界经验教训。
CNS Drugs. 2021 Jul;35(7):743-767. doi: 10.1007/s40263-021-00822-z. Epub 2021 Jul 6.
4
Neurological Consequences of SARS-CoV-2 Infection and Concurrence of Treatment-Induced Neuropsychiatric Adverse Events in COVID-19 Patients: Navigating the Uncharted.新型冠状病毒肺炎(COVID-19)患者中严重急性呼吸综合征冠状病毒2(SARS-CoV-2)感染的神经学后果及治疗引起的神经精神不良事件并发:探索未知领域
Front Mol Biosci. 2021 Feb 18;8:627723. doi: 10.3389/fmolb.2021.627723. eCollection 2021.
5
Current and emerging disease-modulatory therapies and treatment targets for multiple sclerosis.多发性硬化症的现有和新兴疾病调节疗法及治疗靶点。
J Intern Med. 2021 Jun;289(6):771-791. doi: 10.1111/joim.13215. Epub 2020 Dec 20.
6
Psychopharmacology of COVID-19.新型冠状病毒肺炎的精神药理学。
Psychosomatics. 2020 Sep-Oct;61(5):411-427. doi: 10.1016/j.psym.2020.05.006. Epub 2020 May 18.
7
Advances in the treatment of relapsing-remitting multiple sclerosis: the role of pegylated interferon β-1a.复发缓解型多发性硬化症治疗进展:聚乙二醇化干扰素β-1a的作用
Degener Neurol Neuromuscul Dis. 2017 Mar 24;7:47-60. doi: 10.2147/DNND.S71986. eCollection 2017.
8
Interferon-β suppresses murine Th1 cell function in the absence of antigen-presenting cells.在没有抗原呈递细胞的情况下,干扰素-β抑制小鼠Th1细胞功能。
PLoS One. 2015 Apr 17;10(4):e0124802. doi: 10.1371/journal.pone.0124802. eCollection 2015.
9
Multiple sclerosis: An old drug plays a new trick.多发性硬化症:一种老药有了新用途。
Nature. 2013 Oct 17;502(7471):314-5. doi: 10.1038/nature12694. Epub 2013 Oct 9.
10
HERVs in neuropathogenesis.人类内源性逆转录病毒在神经发病机制中的作用。
J Neuroimmune Pharmacol. 2010 Sep;5(3):326-35. doi: 10.1007/s11481-010-9214-y. Epub 2010 Apr 27.